|
What
is gastrointestinal cancer?
The gastrointestinal tract runs from
the mouth to the anus, and includes the oesophagus (gullet),
stomach, small bowel or intestine, and the large bowel
(colon and rectum). Cancer can affect any part of the
gastrointestinal tract, although, curiously, it is rare
in the small intestine where most digestion takes place.
• Bowel cancer (colorectal) is the second commonest
cause of cancer-related death (after lung cancer), affecting
6 per cent of the population in Westernised (industrialised)
countries and causing death in about 3 per cent. About
25 per cent of all deaths are caused by cancer in industrialised
countries, and bowel cancer accounts for 12.5 per cent
of those deaths.
• Stomach cancer accounts for about 8 per cent of
cancer deaths and occurs in twice as many men as women.
It is gradually becoming less common but, sadly, this
fall has been balanced by an increase in oesophageal cancer
(particularly a glandular type called adenocarcinoma)
in men.
• Oesophageal cancer accounts for about 3 per cent
of cancer deaths and the ratio of affected men to women
is 1.8:1.
• Cancer of the pancreas accounts for about 4 per
cent of cancer deaths and affects both sexes approximately
equally.
• Cancer that develops first in the liver (primary
liver cancer) is strongly linked with hepatitis virus
infection. It is uncommon in Western countries where the
rate of hepatitis is relatively low, but is often the
most common cause of cancer-related death in developing
countries where hepatitis is much more frequent. Overall
it accounts for only about 0.7 per cent of cancer deaths
in Western countries. However, the liver is a common site
for other gastrointestinal cancers to spread to, particularly
colorectal cancer, resulting in so-called secondary deposits
or metastatic cancer.
How do I reduce my risk of these cancers?
Several lifestyle changes can reduce your risk of getting
gastrointestinal cancer.
Drink alcohol in moderation
A high alcohol intake is associated with an increased
risk of cancers of the:
• oesophagus - particularly squamous cancer in which
alcoholic spirits and smoking seem to have additive effects.
• pancreas - if high alcohol intake initially leads
to chronic inflammation or pancreatitis, which carries
an increased risk for pancreatic cancer.
• liver - if high alcohol intake leads to liver
cirrhosis, the damage due to chronic inflammation which
is a major risk factor for primary liver cancer.
• bowel.
Avoid smoking
Smoking doubles the risk for cancer of the pancreas
and is, particularly when alcoholic spirits are also drunk,
associated with increased risk for cancer of the oesophagus.
Eat plenty of green vegetables
A high intake of green vegetables is associated
with a reduced risk for bowel cancer and a high vitamin
C intake (found in fruits and green vegetables) is associated
with reduced risk for stomach cancer.
Avoid preserved or burnt meats
Salted and smoked meats are associated with a
high risk of stomach cancer, probably due to their high
content of nitrates which in the stomach form highly carcinogenic
nitroso-amines.
Burnt meats have been found to be linked
with bowel cancer because of their high content of carcinogenic
cyclic amines. A high intake of red meats is particularly
associated with increased risk of bowel cancer.
Keep to a normal weight
Obesity carries an increased risk of bowel cancer.
Obesity also increases the risk of diabetes which itself
is linked with a modestly increased risk of pancreatic
cancer.
Take regular exercise
Regular physical activity is linked with a reduced
risk for bowel cancer, regardless of body weight.
Can screening tests detect gastrointestinal cancers
before they cause symptoms?
Screening is the process of checking people who have
no symptoms for unsuspected disease, which can then be
treated more successfully than if the disease had been
left until it showed itself.
Screening programmes are already in place
for breast cancer and cervical cancer in women. Screening
has been proposed for gastrointestinal cancers. Each cancer
needs to be considered separately but any screening programme
should have certain common properties that are essential
for success:
• the disease should be fairly common in the population
or group of people that is considered to need screening
(otherwise the benefit to any one individual will not
be sufficient to counterbalance the risk and inconvenience
of screening to the rest).
• a diagnostic test to detect the condition is needed
that is simple, cheap and reliable.
• effective treatment should exist.
The last of these properties might seem straightforward
– surely surgery is effective treatment for all
gastrointestinal cancers if they are caught early?
Although this is a reasonable generalisation
this statement is not true in all cases. Many cancers
shed small numbers of cells or 'micrometastases' into
the blood or lymph ducts from a very early stage so removal
of the original (primary) cancer may not cure the patient.
In these cases, the body's own immune response to these
tumour cells seems at least as important as the speed
with which the primary cancer is identified and removed.
|